Centrient Pharmaceuticals joins UNGC
Reinforcing commitment to ethical and sustainable growth
Reinforcing commitment to ethical and sustainable growth
AINU is set to accelerate its expansion footprint, enhance operational capabilities
During this quarter, the company achieved a key milestone of reaching 1,000 DCGI approvals
Cupid reported total income of Rs. 64.75 crore in Q1 FY26 as compared to Rs. 44.03 crore in Q1 Fy25
Our specialty chemical businesses have continued to perform strongly, growing double digit YoY
Novo Nordisk will merge its Research & Early Development and Development functions into a single R&D unit
The latest BioE3 policy builds the framework for high-performance biomanufacturing to propel the development and production
GSK and Hengrui Pharma enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology
Subscribe To Our Newsletter & Stay Updated